Moreover, this interpretation would fit with the higher burden of MS-associated inflammatory lesions, in which an increased expression of the MIF receptor CD74 has been detected [44], and ongoing diffused inflammation [45], in contrast to the short mean disease duration (7 days) across the ON-group. The gene discussed is CD74; the disease is myeloid sarcoma.